cjc 1295 ipamorelin powder cjc-1295 with oral Thymosin Alpha-1: The Immune-Boosting Peptide You Should Know About cjc 1295 ipamorelin research CJC-1295

2.2 Animals and treatments Male Sprague-Dawley (SD) rats (aged 89 weeks, 200220 g) were purchased from the Sipper-BK laboratory animal CO., Ltd

You get the strong, sustained signal from Tesamorelin combined with the clean, targeted pulse from Ipamorelin (a highly selective GHRP)

Ipamorelin hits the GHRP receptor and says "release GH now." CJC-1295 (no DAC) hits the GHRH receptor and says "amplify that release." When dosed together: CJC-1295 primes the pituitary and increases the available pool of GH Ipamorelin triggers the acute release of that pool The combined pulse is substantially larger than either compound generates alone research suggests synergistic effects in the range of 210x depending on baseline GH status and dosing This works because the two compounds bind to completely separate receptors

Tesamorelin/Ipamorelin Blend (taken directly from the Peptide Cheat Sheet): The BioLongevity Labs blend comes as a 6mg/2mg vial (tesamorelin/ipamorelin)